Clinicalusedefinition-indication-example

FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example ClinicalUseDefinition/example-indication (Narrative)

Biomedical Research and Regulation Work Group

Maturity Level: N/A

Standards Status: Informative

Compartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile ClinicalUseDefinition.

Generated Narrative: ClinicalUseDefinition example-indication

StructureDefinition Work Group: brr

type: indication

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/example/MPID#{mpid}; classification = B01AF02

indication
DiseaseSymptomProcedures

- Concept

* Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery. Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II). Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.
DiseaseStatuses

- Concept

* Recurrent
IntendedEffects

- Concept

* PRYLX

population: Group: type = person; membership = definitional

Generated Narrative: Group #group

type: person
membership: definitional
Characteristics

- Code Value[x] Exclude

* age-range 18-? a false

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.